1
|
Boerboom D, Pilon N, Behdjani R,
Silversides DW and Sirois J: Expression and regulation of
transcripts encoding two members of the NR5A nuclear receptor
subfamily of orphan nuclear receptors, steroidogenic factor-1 and
NR5A2, in equine ovarian cells during the ovulatory process.
Endocrinology. 141:4647–4656. 2000. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ikeda Y, Lala DS, Luo X, Kim E, Moisan MP
and Parker KL: Characterization of the mouse FTZ-F1 gene, which
encodes a key regulator of steroid hydroxylase gene expression. Mol
Endocrinol. 7:852–860. 1993. View Article : Google Scholar : PubMed/NCBI
|
3
|
Stein S and Schoonjans K: Molecular basis
for the regulation of the nuclear receptor LRH-1. Curr Opin Cell
Biol. 33:26–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lazarus KA, Wijayakumara D, Chand AL,
Simpson ER and Clyne CD: Therapeutic potential of liver receptor
homolog-1 modulators. J Steroid Biochem Mol Biol. 130:138–146.
2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Fayard E, Auwerx J and Schoonjans K:
LRH-1: An orphan nuclear receptor involved in development,
metabolism and steroidogenesis. Trends Cell Biol. 14:250–260. 2004.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Lee YK and Moore DD: Liver receptor
homolog-1, an emerging metabolic modulator. Front Biosci.
13:5950–5958. 2008. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Out C, Hageman J, Bloks VW, Gerrits H,
Gelpke Sollewijn MD, Bos T, Havinga R, Smit MJ, Kuipers F and Groen
AK: Liver receptor homolog-1 is critical for adequate up-regulation
of Cyp7a1 gene transcription and bile salt synthesis during bile
salt sequestration. Hepatology. 53:2075–2085. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Venteclef N, Haroniti A, Tousaint JJ,
Talianidis I and Delerive P: Regulation of anti-atherogenic
apolipoprotein M gene expression by the orphan nuclear receptor
LRH-1. J Biol Chem. 283:3694–3701. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Oosterveer MH, Mataki C, Yamamoto H,
Harach T, Moullan N, van Dijk TH, Ayuso E, Bosch F, Postic C, Groen
AK, et al: LRH-1-dependent glucose sensing determines intermediary
metabolism in liver. J Clin Invest. 122:2817–2826. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Stergiopoulos A and Politis PK: Nuclear
receptor NR5A2 controls neural stem cell fate decisions during
development. Nat Commun. 7:122302016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Nadolny C and Dong X: Liver receptor
homolog-1 (LRH-1): A potential therapeutic target for cancer.
Cancer Biol Ther. 16:996–1004. 2015. View Article : Google Scholar
|
12
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer; New York: 2010
|
13
|
Kang X, Zhang L, Wu R, Sheng X, Sun J and
Chen X: The expression of prohibitin in gastrointestinal cancer
tissue and its clinical signification. Laborat Med. 21:610–612.
2006.
|
14
|
Li YX, Zhang J, Qian Y, Meng CH, Wang HL,
Tao XJ, Zhong S, Cao SX and Li QF: Molecular characterization,
expression, polymorphism of NR5A2 and its relationship with litter
size in Hu sheep. Genet Mol Res. 14:12765–12775. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tan XH, Cheng R, Hu HP and Bai YP:
Classification of colon cancer based on the expression of randomly
selected genes. Genet Mol Res. 14:12628–12635. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ding M, Li X and Qiu T: Combination of
multiple gene markers to detect circulating tumor cells in the
peripheral blood of patients with non-small cell lung cancer using
real-time PCR. Genet Mol Res. 14:13033–13040. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Fernandez-Marcos PJ, Auwerx J and
Schoonjans K: Emerging actions of the nuclear receptor LRH-1 in the
gut. Biochim Biophys Acta. 1812:947–955. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Gao W, Tang Z, Zhang YF, Feng M, Qian M,
Dimitrov DS and Ho M: Immunotoxin targeting glypican-3 regresses
liver cancer via dual inhibition of Wnt signalling and protein
synthesis. Nat Commun. 6:65362015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Benod C, Vinogradova MV, Jouravel N, Kim
GE, Fletterick RJ and Sablin EP: Nuclear receptor liver receptor
homologue 1 (LRH-1) regulates pancreatic cancer cell growth and
proliferation. Proc Natl Acad Sci USA. 108:16927–16931. 2011.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Falender AE1, Lanz R, Malenfant D,
Belanger L and Richards JS: Differential expression of
steroidogenic factor-1 and FTF/LRH-1 in the rodent ovary.
Endocrinology. 144:3598–3610. 2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhang X, Gu D, Du M, Wang M, Cao C, Shen
L, Kuang M, Tan Y, Huo X, Gong W, et al: Associations of NR5A2 gene
polymorphisms with the clinicopathological characteristics and
survival of gastric cancer. Int J Mol Sci. 15:22902–22917. 2014.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Kramer HB, Lai CF, Patel H, Periyasamy M,
Lin ML, Feller SM, Fuller-Pace FV, Meek DW, Ali S and Buluwela L:
LRH-1 drives colon cancer cell growth by repressing the expression
of the CDKN1A gene in a p53-dependent manner. Nucleic Acids Res.
44:582–594. 2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Bayrer JR, Mukkamala S, Sablin EP, Webb P
and Fletterick RJ: Silencing LRH-1 in colon cancer cell lines
impairs proliferation and alters gene expression programs. Proc
Natl Acad Sci USA. 112:2467–2472. 2015. View Article : Google Scholar : PubMed/NCBI
|